Clinical Trials Directory

Trials / Completed

CompletedNCT01323868

Endogenous Endophthalmitis in the Inpatient Setting

Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
145 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.

Detailed description

Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis). Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital.

Conditions

Timeline

Start date
2010-07-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2011-03-28
Last updated
2014-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01323868. Inclusion in this directory is not an endorsement.